(Q44342495)

2 December 2017

title

Changes in prevalence of prescription opioid abuse after introduction of an abuse-deterrent opioid formulation (English)

1 reference

2 December 2017

0 references

1 reference

5

1 reference

2 December 2017

Theresa A Cassidy

1

1 reference

2 December 2017

Pronabesh DasMahapatra

series ordinal

2

1 reference

2 December 2017

Ryan A Black

series ordinal

3

1 reference

2 December 2017

Matthew S Wieman

series ordinal

4

1 reference

2 December 2017

publication date

11 December 2013

1 reference

2 December 2017

1 reference

2 December 2017

volume

15

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

440-451

1 reference

Abuse-deterrent opioid formulations: are they a pipe dream?

2 December 2017

cites work

1 reference

Can abuse deterrent formulations make a difference? Expectation and speculation

21 January 2018

1 reference

Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment

21 January 2018

1 reference

Opioid formulations designed to resist/deter abuse

21 January 2018

1 reference

National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuse

21 January 2018

1 reference

The Addiction Severity Index: reliability and validity in a Dutch addict population

21 January 2018

1 reference

The Fifth Edition of the Addiction Severity Index

21 January 2018

1 reference

Initial validation of a computer-administered Addiction Severity Index: the ASI-MV.

21 January 2018

1 reference

Validation of the Spanish Addiction Severity Index Multimedia Version (S-ASI-MV).

21 January 2018

1 reference

Abuse risks and routes of administration of different prescription opioid compounds and formulations

21 January 2018

1 reference

A modified poisson regression approach to prospective studies with binary data

21 January 2018

1 reference

A profile of OxyContin addiction

21 January 2018

1 reference

Abuse-deterrent and tamper-resistant opioid formulations: what is their role in addressing prescription opioid abuse?

21 January 2018

1 reference

Abuse of buprenorphine in the United States: 2003-2005.

21 January 2018

1 reference

Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users.

21 January 2018

1 reference

Prescription OxyContin abuse among patients entering addiction treatment

21 January 2018

1 reference

Tampering with prescription opioids: nature and extent of the problem, health consequences, and solutions.

21 January 2018

1 reference

Typologies of prescription opioid use in a large sample of adults assessed for substance abuse treatment

21 January 2018

1 reference

Internet-based survey of nonmedical prescription opioid use in the United States

21 January 2018

1 reference

Assessment of a formulation designed to be crush-resistant in prescription opioid abusers

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/PME.12295

1 reference

2 December 2017

1 reference